Ru Liu
Department of Ophthalmology, the Second Xiangya Hospital Central South University, Changsha 410011, Hunan Province, ChinaXiao-Huan Zhang
Department of Ophthalmology, the Second Xiangya Hospital Central South University, Changsha 410011, Hunan Province, ChinaKun Zhang
Department of Ophthalmology, the Second Xiangya Hospital Central South University, Changsha 410011, Hunan Province, ChinaWei Li
Department of Ophthalmology, the Second Xiangya Hospital Central South University, Changsha 410011, Hunan Province, ChinaWen-Jun Wang
Department of Ophthalmology, the Second Xiangya Hospital Central South University, Changsha 410011, Hunan Province, ChinaDi-Xian Luo
Institute of Translational Medicine, the First People’s Hospital of Chenzhou City, Chenzhou 423000, Hunan Province ,ChinaLing Gao
Department of Ophthalmology, the Second Xiangya Hospital Central South University, Changsha 410011, Hunan Province, ChinaSupported by the National Natural Science Foundation of China (No.3087282; No.81072221).
Conflicts of Interest: Liu R, None; Zhang XH, None; Zhang K, None; Li W, None; Wang WJ, None; Luo DX, None; Gao L, None.
ACKNOWLEDGEMENTS: The authors thank Dr. De-Liang Cao in Department of Microbiology, Immunology and Cell Biology, Simmons Cancer Institute, Southern Illinois University School of Medicine for proofreading this article. The authors thank Guang-Xiu Lu for approval of the project, which was undertaken in the Institute of Reproduction and Stem Cell Engineering, and all the researchers in the Institute for technical support.
Ru Liu, Xiao-Huan Zhang, Kun Zhang,/et al.5-Aza-2’-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene. Int J Ophthalmol, 2014,7(1):51-56
Copy